A leading manufacturer of high-end parenteral nutrition products, the company offers 16 parenteral nutrition formulations and one high-end controlled-release formulation. Four of its amino acid products are included in the *Expert Consensus on the Clinical Application of Compound Amino Acid Injections.

The product pipeline covers more than ten therapeutic areas, including antidepressants, antibacterial and anti-inflammatory agents, men's health, and cardiovascular diseases, such as novel eye drops, new formulations for treating dysmenorrhea, and antifungal drugs.

Equipped with a pharmaceutical-grade freeze-drying production line, featuring high-precision freeze-dryers, aseptic filling systems, and a comprehensive GMP quality management system, we offer one-stop freeze-drying solutions ranging from formulation development and pilot-scale validation to small-scale, pilot, and large-scale production.

To date, the company has undergone six on-site inspections to expand the scope of its manufacturing license and three GMP compliance inspections, covering a total of 10 products. Of these, registration for the active ingredients, excipients, and packaging materials of five products has been completed.

We provide integrated services encompassing the research, development, production, and sales of intermediates and APIs; large-volume parenteral solutions (glass vials); large-volume parenteral solutions (flexible bags); specialized production lines for bottled emulsion-in-oil; small-volume sterile parenteral solutions; and oral solid dosage forms (hard capsules, granules, and tablets).